co-presented by
ASSOCIATE SPONSORS
co-presented by
ASSOCIATE SPONSORS
Max Financial Services has delivered a horizontal trendline breakout on the daily chart, backed by steady follow-through and rising volumes, which strengthens the validity of the move said Sudeep Shah.
Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated January 29, 2026.
Choice Institutional Equities recommended reduce rating on Piramal Pharma with a target price of Rs 160 in its research report dated January 29, 2026.
Revenue from operations declined 3% to Rs.2,140 crore, pulled down primarily by a 9 percent fall in the CDMO segment
Stocks to Watch, 12 December: Stocks like Piramal Pharma, Infosys, Rama Steel Tubes, Firstsource Solutions, Kirloskar Ferrous Industries, Kansai Nerolac Paints, TRF, NBCC (India), Vedanta, RRP Defense, Honasa Consumer, Tata Power Company, Cyient, and Uflex will be in focus on December 12.
Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 240 in its research report dated November 06, 2025.
ICICI Securities is bullish on Piramal Pharma recommended buy rating on the stock with a target price of Rs 265 in its research report dated July 29, 2025.
Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 240 in its research report dated July 29, 2025.
The market may see further consolidation with a negative bias if it breaks Monday’s low in the upcoming sessions. Below are some short-term trading ideas to consider.
Stocks to Watch, 4 July: Stocks like Bajaj Finance, Suryoday Small Finance Bank, Bank of Baroda, RBL Bank, AWL Agri Business, Marico, Emcure Pharmaceuticals, Piramal Pharma, Sterling Powergensys, Godavari Biorefineries, Indian Energy Exchange, InterGlobe Aviation, Force Motors, and FSN E-Commerce Ventures Nykaa will be in focus on July 4.
Carlyle picked up a 20% stake in Piramal Pharma for Rs 3,523 crore (approximately $490 million) in June 2020
ICICI Securities is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 280 in its research report dated May 15, 2025.
Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 250 in its research report dated May 15, 2025.
With the stock showing significant movement and positive sentiment, investors will be closely monitoring Piramal Pharma's performance in the coming sessions.
Stocks to Watch, Mar 21: Stocks like Lloyds Metals and Energy, Ashoka Buildcon, CG Power and Industrial Solutions, Unichem Laboratories, Happiest Minds Technologies, Piramal Pharma, Power Finance Corporation, Asian Paints, Container Corporation of India, Tamilnad Mercantile Bank, and Endurance Technologies will be in focus on March 21.
Piramal Pharma Share Price | The company's Q3FY25 consolidated profit plunged 63.6 percent to Rs 3.68 crore versus Rs 10.1 crore, while revenue rose 12.5 percent to Rs 2,204.2 crore versus Rs 1,958.6 crore, YoY.
Stocks To Watch, Feb 19: Stocks like Indian Overseas Bank, Larsen & Toubro, Container Corporation of India, Cello World, RBM Infracon, Bharti Airtel, Voler Car, PS Raj Steels, and Maxvolt Energy Industries will be in focus on February 19.
